Page 1928 - Hall et al (2015) Principles of Critical Care-McGraw-Hill
P. 1928

Index        1355


                    Septic shock, 229f, 236, 236t, 259, 563  pulmonary hypertension, 910–911, 911f  Solid organ infiltration, 868
                     in pregnancy, 1260–1261, 1260t        sepsis and meningitis, 911       Soluble clotting factors, coagulation cascade
                    Sequential Organ Failure Assessment (SOFA)  splenic sequestration and infarction,   and, 846–847, 847t
                     scoring system, 85, 88, 89                911–912                      Soluble triggering receptor expressed on
                     sepsis and, 568–569                   stroke, 911                             myeloid cells, sepsis and, 567
                    Serotonin syndrome, 560, 561t        treatments, 912–914                Source control, for sepsis, 570
                    Severe sepsis, 937–938                 analgesics, 912–913, 912t, 913t  South American hemorrhagic fevers, 739
                    Severity index score, 568, 568t        glucocorticoids, 914             Specificity of test, 47
                    Shingles, 670                          hydroxyurea, 914                 Specific metabolic disorders, acid-base
                    Shock, 249–262                         incentive spirometry, 913               balance and, 969–970
                     adrenal, 238                          investigational, 914             Spectrum of disability, clinical phenotypes in
                                  https://kat.cr/user/tahir99/
                     anaphylactic, 238, 260                oxygen and fluids, 912                  critical illness and, 107–108, 108f
                     cardiogenic, 229f, 236–237, 256–257t,   transfusion, 913–914, 913t, 914t  Spider bite, 1222–1223
                           258–259, 306–307, 306f       Silent ischemia, 295                Spinal cord injuries, 1178
                     circulatory, 243                   Simple hemopneumothorax, 1160       Spinal injuries, 1137–1152, 1138t, 1139f
                     defined, 249–250                   Simplified acute physiology score,    airway, breathing, and respiratory issues,
                     electric, 1176                            sepsis and, 568                     1142–1144
                     establishing working diagnosis of cause of,   Simplified Acute Physiology Score (SAPS II)   complications, 1143–1144, 1143f
                           249–250, 250f                       scoring system, 93, 94, 379     ventilator weaning and
                     hypovolemic, 237, 254–256, 254f, 255–256,   Sinusitis, 524–525, 559           tracheostomy, 1144
                           255f, 260                     nosocomial, 686                     bleeding and transfusion issues, 1146
                     inflammatory component of, 260     Sinus tachycardia, 498               cervical spine clearance, 1150
                     multiple etiologies of, 238        Sirolimus, 1089, 1100                classification of vertebral injuries,
                     neurogenic, 238, 260               Skeletal system, sickle cell disease       1138–1139, 1140t
                     obstructive, 258                          and, 907                      diagnostic imaging, 1141–1142,
                     organ system pathophysiology of,    Skin, sickle cell disease and, 907        1141f, 1142f
                           260–261                      Skull fractures, 1122, 1122f         epidemiology of, 1138
                     right heart dysfunction as cause of, 309  Sleep, 155–161                gastrointestinal tract issues, 1152
                     role of fluids in, 263              after intensive care, 161           general management issues after
                     septic, 229f, 236, 236t, 259, 563   architecture, 156–157, 157f               acute, 1141
                     spinal, 1145–1146                   circadian rhythmicity in critically ill   genitourinary tract issues, 1152
                     therapeutic interventions and, 261        patient, 158–159              health care-associated infections, 1151
                     treatment of, 728                   in critically ill patient, 159–161, 159t  hemodynamic issues
                     types of, 254–256, 257t, 258–260    mechanical ventilation and, 159–160   autonomic dysreflexia, 1145
                     untreated, 261                      physiologic changes during normal,    cardiovascular complications and
                     urgent initial resuscitation, 250–254, 251t,   157–158                        neurogenic shock, 1144–1146, 1145f
                           252f, 253t                    potential adverse effects of disruption in   management of instability, 1145
                    Shock liver, 1001                          critically ill patients, 158, 158t  monitoring, 1144
                    Shock lung, 261                      promoting, in intensive-care unit, 161  spinal shock, 1145–1146
                    Shock-wave lithotripsy, 213          sedation and, 160–161, 160t         intensive care unit management, 1142
                    Sickle cell anemia, 903              sleep-wake regulation, 156          neurological outcome, 1152
                    Sickle cell disease, 902–914, 903f  Sleep deprivation, 157               neuroprotection, 1150
                     baseline physiology, 904–905,      Slow continuous ultrafiltration (SCUF), 933  neurosurgical management issues,
                           905t, 906ft                  Small bowel feeding, role of, 137          1146–1147, 1146f, 1147f, 1148f,
                     common clinical problems, 906–907  Small bowel obstruction, 1005–1006,        1149–1150, 1149f
                       eye disease, 906                        1020–1021                     nutritional support issues, 1151
                       heart disease, 906–907           Smallpox, 749–750, 1302                glycemic control, 1151
                       hepatobiliary, 907               Snake bite, 1222                     primary versus secondary, 1139–1140
                       lung disease, 906                Snare device, 226                    rehabilitation, 1152
                       renal, 907                       Society of Interventional Radiology   sedation issues, 1151
                       skeletal, 907                           Guidelines, for use of inferior vena   temperature regulation and hypothermia,
                       skin, 907                               cava (IVC) filters, 221             1150–1151
                       splenic, 907                     Sodium, 944–950                      venous thromboembolism, 1151
                       stroke, 906                       hypernatremia, 945–947, 946ft, 947f  Spinal paralysis, 1320
                       vaso-occlusive pain crisis, 906   hyponatremia, 947–950, 947f, 948ft  Spinal shock, 1145–1146
                     general background for, 902–903     metabolism, 944–945, 944t          Spiritual support, in palliative care,
                     genetics and epidemiology, 903     Sodium nitroprusside, 364                  122–123
                     homozygous, 903                    Sodium thiosulfate, 1215            Spleen injuries, 1165
                     pathophysiology, 904, 904t, 905f   Soft tissue infections, 688–695     Splenic abscess, 1082
                     special problems in intensive care unit,   classification of, 688–690, 689t  Splenic sequestration, 911–912
                           907–912, 907t                 major, 690–695                      sickle cell disease and, 912
                       acute chest syndrome, 907–908, 908t,   anaerobic cellulitis, 691     Splenic system, sickle cell disease
                           909f, 910, 910t                 cellulitis, 690–691                     and, 907
                       perioperative management of, 912    myonecrosis, 694–695, 694f       Splinter hemorrhages, 1299
                       priapism, 912                       necrotizing fasciitis, 691–694, 692f, 693f  SpO 2 , clinical uses of, 243










            Index.indd   1355                                                                                           23-01-2015   15:33:54
   1923   1924   1925   1926   1927   1928   1929   1930   1931   1932   1933